Clinical significance of urinary soluble CD11b and CD163 receptor levels in ANCA-associated vasculitides
Open Access
- 18 October 2025
- journal article
- Published by IMA Press, LLC in Modern Rheumatology Journal
- Vol. 19 (5) , 26-33
Abstract
Objective. To assess the diagnostic value of urinary soluble CD11b and CD163 receptor levels (U-CD11b and U-CD163) in patients with antineutrophil cytoplasmic antibody-associated systemic vasculitides (AAV).Material and methods. This cross-sectional study included 48 patients (21 men, 27 women; median age 52 [31; 67] years) with a confirmed diagnosis of AAV: granulomatosis with polyangiitis (GPA) in 38, microscopic polyangiitis (MPA) in 8, and eosinophilic granulomatosis with polyangiitis in 2. Patients were stratified into two groups: Group 1, AAV without kidney involvement (n=25); Group 2, AAV with kidney involvement (n=23). A comparison Group 3 comprised 13 patients with systemic lupus erythematosus (SLE) and biopsy-proven kidney involvement (4 men, 9 women; median age 34 [29.0; 43.4] years). All patients underwent standard clinical, laboratory, and instrumental evaluations. U-CD11b and U-CD163 were measured by ELISA using kits ELH-ITGAM-1 (human CD11b) and DC1630 (human CD163) (China). Reference values for U-CD11b and U-CD163, established as the 95th percentile in volunteers without autoimmune disease, were 5.7 and 41.4 ng/mL, respectively. In 10 patients (2 with GPA, 1 with MPA, and 7 with SLE) glomerulonephritis (GN) was verified by vital renal biopsy.Results and discussion. GN was identified in 36 patients (23 with AAV, 13 with SLE). U-CD11b level was significantly higher in 8 (61.5%) SLE patients than in 22 (46%) AAV patients (median 8.2 [4.5; 11.1] and 5.1 [2.7; 8.1] ng/mol, respectively; p=0.02). Conversely, U-CD163 level was higher in 13 (48%) AAV patients (median 29.8 [3.5; 159.1] ng/mmol) than in 6 (46.1%) SLE patients (22.6 [12.7; 148.5] ng/mol), p=0.04. Elevated U-CD11b was detected more frequently in SLE and in AAV with kidney involvement than in AAV without kidney involvement (61.5%, 56.5%, and 36%, respectively; p=0.001), with the highest median in Group 3 (median 8.2 [4.5; 11.1] ng/mmol). Elevated U-CD163 was more frequent in Groups 3 and 2 than in Group 1 (46.1%, p=0.009; 43.4%, p=0.025; and 12%, respectively), with the highest median in Group 2 (34.9 [9.3; 159.1] ng/mmol). However, between-group differences in the frequencies of elevated U-CD11b and U-CD163 were not statistically significant. In Group 1, increases in U-CD11b (36% of cases) and U-CD163 (12%) levels were also observed. Elevated biomarker levels were associated with higher disease activity but not with GN morphological classes in AAV or SLE.Conclusion. U-CD11b and U-CD163 levels may reflect the severity of renal inflammatory involvement in patients with AAV and SLE. Further studies are needed to determine the diagnostic utility of these biomarkers.Keywords
This publication has 46 references indexed in Scilit:
- Ligand binding initiates single-molecule integrin conformational activationCell, 2024
- 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Microscopic PolyangiitisArthritis & Rheumatology, 2022
- 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With PolyangiitisArthritis & Rheumatology, 2022
- 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis With PolyangiitisArthritis & Rheumatology, 2022
- Clinical associations of renal involvement in ANCA-associated vasculitisAutoimmunity Reviews, 2020
- The macrophage-related biomarkers sCD163 and sCD206 are released by different shedding mechanismsJournal of Leukocyte Biology, 2019
- Monocytes Promote Crescent Formation in Anti-Myeloperoxidase Antibody–Induced GlomerulonephritisThe American Journal of Pathology, 2017
- 2012 Revised International Chapel Hill Consensus Conference Nomenclature of VasculitidesArthritis & Rheumatism, 2012
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosusArthritis & Rheumatism, 2012
- Shedding of CD163, a Novel Regulatory Mechanism for a Member of the Scavenger Receptor Cysteine-Rich FamilyBiochemical and Biophysical Research Communications, 1999